aDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, WA;

bDepartment of Global Health, University of Washington, Seattle, WA;

cPATH-Kenya, Kisumu, Kenya;

dDepartment of Biostatistics, University of Washington, Seattle, WA;

eDepartment of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA;

fSchool of Nursing, University of Washington, Seattle, WA;

gMinistry of Health, Nairobi, Kenya;

hKenya Medical Research Institute (KEMRI), Nairobi, Kenya; and

iDepartment of Medicine, University of Washington, Seattle, WA.

Correspondence to: Unmesha Roy Paladhi, MPH, PhD, Brigham and Women's Hospital, Harvard Medical School, Harvard University, 15 Francis St., Boston, MA 21115 (e-mail: [email protected]).

This study was funded by the US National Institute of Allergy and Infectious Diseases of the National Institutes of Health (grant number R01AI134130). MS received support from the National Institutes of Mental Health (grant number K01MH115789). S.M. received support from the Fogarty International Center (grant numbers D43 TW009580, D43 TW009783, and D43 TW010905). The study received additional support from the University of Washington/Fred Hutch Center for AIDS Research, an NIH-funded program (grant number P30 AI027757).

Conference on Retroviruses and Opportunistic Infections (CROI) 2024 in Denver, Colorado, 3-6 March 2024.

The authors have no funding or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).

E.K. and C.F. co-senior authors.